By Stewart Eisenhart, Emergo Group
Brazilian medical device market regulator ANVISA has reported a major increase in medical device modification applications received over the past three months compared to the first half of 2018 following changes to importation and inspection requirements.
Get the full story here at the Emergo Group’s blog.
The opinions expressed in this blog post are the author’s only and do not necessarily reflect those of DrugDeliveryBusiness.com or its employees.